Peptalk’s two-part Intelligent Antibody Discovery conference examines the technologies, informatics, and strategies driving a move to improve the quality, precision, and developability of biotherapeutic selections. Part One examines new capabilities of next-generation sequencing tools and strategies for developing high-throughput functional assays.
1. Medical 2. Research 3. Biotech 4. Education 5. Conferences
At Cambridge Healthtech Institute (CHI), we believe bringing together a unique and diverse constellation of innovators, scientists, and life science professionals can hold the key to developing tomorrow’s cures and diagnostics.